Diagnostic Challenges in Disseminated Mycobacterium szulgai Infection: A Case Report in the Setting of Advanced HIV Infection
Abstract
Mycobacterium szulgai is a rare, slow-growing non-tuberculous mycobacterium (NTM), accounting for less than 0.2% of NTM isolates worldwide. It most often presents with pulmonary disease resembling tuberculosis, while disseminated infection is exceptionally uncommon and typically occurs in immunocompromised hosts. We report a 34-year-old male newly diagnosed with advanced HIV infection who presented with painful cutaneous nodular lesions, intermittent fever, anorexia, and significant weight loss. Initial investigations suggested cutaneous nocardiosis or fungal infection, with cultures yielding Aspergillus niger and Corynebacterium species. Despite antifungal and antibacterial therapy, his condition progressed to multifocal cutaneous lesions, oral mucosal involvement, and osteomyelitis of the tibia and fibula. An extended microbiological evaluation of a bone biopsy revealed acid-fast bacilli, and cultures identified M. szulgai via rpoB gene sequencing and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). Further imaging and bronchoalveolar lavage confirmed disseminated infection involving lungs, skin, and bone. The patient was treated with rifampicin, ethambutol, and moxifloxacin in combination with antiretroviral therapy. After six months, complete resolution of cutaneous lesions, regression of pulmonary nodules, and normalization of inflammatory markers were achieved. Therapy was planned for 12-18 months. This case underscores the…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.